Kazia Therapeutics (KZIA) Total Liabilities (2009 - 2025)
Kazia Therapeutics (KZIA) posted Total Liabilities of $16.2 million for Q4 2025, up 75.94% on a QoQ basis from $9.2 million in Q2 2025, and up 13.93% year-over-year from $14.2 million in Q4 2024.
Kazia Therapeutics (KZIA) has 14 years of Total Liabilities data on file, last reported at $16.2 million in Q4 2025.
- In Q4 2025, Total Liabilities rose 13.93% year-over-year to $16.2 million; the TTM figure through Dec 2025 stood at $16.2 million (up 13.93% YoY), while the FY2025 annual figure was $9.2 million, down 55.84% from the prior year.
- Total Liabilities advanced to $16.2 million in Q4 2025, from $9.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $20.8 million in Q2 2024 and bottomed at $9.2 million in Q2 2025.
- A 5-year average of $13.6 million and a median of $12.6 million in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2021 — Total Liabilities surged 166.02% — and 2025, when it sank 55.84%.
- Year by year, Total Liabilities stood at $15.6 million in 2021, then tumbled by 31.48% to $10.7 million in 2022, then gained by 16.54% to $12.4 million in 2023, then gained by 14.14% to $14.2 million in 2024, then advanced by 13.93% to $16.2 million in 2025.
- The last three Total Liabilities figures came in at $16.2 million (Q4 2025), $9.2 million (Q2 2025), and $14.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | 16.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.18 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Dec 31, 2024 | 14.20 Mn |
| Jun 30, 2024 | 20.83 Mn |
| Dec 31, 2023 | 12.44 Mn |
| Jun 30, 2023 | 10.72 Mn |
| Dec 31, 2022 | 10.68 Mn |
| Jun 30, 2022 | 12.62 Mn |
| Jun 30, 2021 | 15.58 Mn |
| Dec 31, 2020 | 5.80 Mn |
| Jun 30, 2020 | 5.86 Mn |
| Dec 31, 2019 | 5.63 Mn |
| Jun 30, 2019 | 4.89 Mn |
| Dec 31, 2018 | 5.19 Mn |
| Jun 30, 2018 | 6.76 Mn |
| Jun 30, 2017 | 7.94 Mn |
| Dec 31, 2016 | 9.04 Mn |
| Jun 30, 2016 | 7.89 Mn |
| Jun 30, 2012 | 3.91 Mn |
| Dec 31, 2011 | 5.40 Mn |
| Jun 30, 2011 | 8.82 Mn |
| Dec 31, 2010 | 3.51 Mn |
| Jun 30, 2010 | 5.40 Mn |
| Dec 31, 2009 | 3.27 Mn |
| Jun 30, 2009 | 6.88 Mn |